[Translation] A randomized, double-blind, single-dummy, placebo-controlled, multicenter phase II clinical trial of Jiangzhininggan capsule in the treatment of nonalcoholic fatty liver disease-phlegm and blood stasis syndrome
初步评价降脂宁肝胶囊治疗非酒精性单纯性脂肪肝-痰瘀互结证的有效性和安全性,探索安全有效剂量,为Ⅲ期临床试验提供用药依据。
[Translation] To preliminarily evaluate the efficacy and safety of Jiangzhininggan Capsule in the treatment of non-alcoholic simple fatty liver disease-phlegm and blood stasis syndrome, explore the safe and effective dose, and provide a basis for medication for Phase III clinical trials.